These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 907355)

  • 1. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
    Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
    Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
    [No Abstract]   [Full Text] [Related]  

  • 2. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
    Basu A; Glew RH; Daniels LB; Clark LS
    J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of the heat-stable glucocerebrosidase activator substance in Gaucher spleen.
    Chiao YB; Chambers JP; Glew RH; Lee RE; Wenger DA
    Arch Biochem Biophys; 1978 Feb; 186(1):42-51. PubMed ID: 629536
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue acid hydrolase activities in Gaucher's disease.
    Ockerman PA; Köhlin P
    Scand J Clin Lab Invest; 1968; 22(1):62-4. PubMed ID: 5706652
    [No Abstract]   [Full Text] [Related]  

  • 6. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
    Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
    Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
    Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
    Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of lysosomal hydrolases that are elevated in Gaucher's disease.
    Moffitt KD; Chambers JP; Diven WF; Glew RH; Wenger DA; Farrell DF
    Arch Biochem Biophys; 1978 Sep; 190(1):247-60. PubMed ID: 101149
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
    Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
    Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin and parvalbumin: activators of human liver glucocerebrosidase.
    Glew RH; Coffee CJ
    Arch Biochem Biophys; 1984 Feb; 229(1):55-63. PubMed ID: 6422854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of low molecular weight glycoprotein effector of lipid glycosidase.
    Ho MW
    FEBS Lett; 1975 May; 53(2):243-7. PubMed ID: 1140409
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
    Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease.
    Pirruccello S; Barranger JA; Barton NW; Brady RO; Ginns EI
    Biochem Med; 1984 Feb; 31(1):73-9. PubMed ID: 6743300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence of beta-glucocerebrosidase activity in the glucocerebroside-rich deposits of Gaucher's disease.
    Glew RH; Christopher AR; Schnure FW; Lee RE
    Arch Biochem Biophys; 1974 Jan; 160(1):162-7. PubMed ID: 4364062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.